Emory university
Atlanta, Georgia 39322
216 studies enrolling now · 1398 studies all time
What they study most
1 Paravisceral Abdominal Aortic Aneurysm, 2 Juxtarenal Abdominal Aortic Aneurysm, 3 Pararenal Abdominal Aortic Aneurysm, 4 Complex Abdominal Aortic Aneurysms, ACL Tear, ADPKD, AIDS-Related Opportunistic Infections, ALL, ALS, ALS (Amyotrophic Lateral Sclerosis), AML, AML With Gene Mutations
Studies at this site
- A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — Recruiting now
- A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment — Recruiting now
- LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve — Recruiting now
- A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) — Recruiting now
- A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — Recruiting now
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease — Recruiting now
- PREcision MEDicine In Achalasia (PREMEDIA) - Cohort — Recruiting now
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy — Recruiting now
- Thrive With Type 1 Diabetes 2026 — Recruiting now
- The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy — Recruiting now
- Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study — Recruiting now
- Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
- A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer — Recruiting now
- Incremental Hemodialysis: The TwoPlus Trial — Recruiting now
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) — Recruiting now
- Study of COYA 302 for the Treatment of ALS — Recruiting now
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses — Recruiting now
- Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
- A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment — Recruiting now
- Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
- A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib — Recruiting now
- Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS — Recruiting now
- Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough — Recruiting now
- Adult and Juvenile Myositis — Recruiting now
- Screening Volunteers for Clinical Trials — Recruiting now
- Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System — Recruiting now
- Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias — Recruiting now
- ELEVATE-HFpEF Clinical Study — Recruiting now
- A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis — Recruiting now
- A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma — Recruiting now
- The Oxford Risk Factors And Non-Invasive Imaging Study — Recruiting now
- A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer — Recruiting now
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants — Recruiting now
- A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
- The OBSERVE Protocol — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures — Recruiting now
- A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
- A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms — Recruiting now
- A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
- PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study — Recruiting now
- Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients — Recruiting now
- An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) — Recruiting now
- Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors — Recruiting now
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study — Recruiting now
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Recruiting now
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) — Recruiting now
- AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors — Recruiting now
- A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) — Recruiting now
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors — Recruiting now